CN108713760A - 一种抗疲劳护眼营养液及其制备方法 - Google Patents
一种抗疲劳护眼营养液及其制备方法 Download PDFInfo
- Publication number
- CN108713760A CN108713760A CN201810456608.3A CN201810456608A CN108713760A CN 108713760 A CN108713760 A CN 108713760A CN 201810456608 A CN201810456608 A CN 201810456608A CN 108713760 A CN108713760 A CN 108713760A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- vitamin
- microcapsule powder
- zeaxanthin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 17
- 239000007788 liquid Substances 0.000 title claims abstract description 17
- 235000008935 nutritious Nutrition 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims description 9
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 38
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 37
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 28
- 239000003094 microcapsule Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims abstract description 19
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims abstract description 19
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims abstract description 19
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims abstract description 19
- 229960003080 taurine Drugs 0.000 claims abstract description 19
- 235000010930 zeaxanthin Nutrition 0.000 claims abstract description 19
- 239000001775 zeaxanthin Substances 0.000 claims abstract description 19
- 229940043269 zeaxanthin Drugs 0.000 claims abstract description 19
- 235000015097 nutrients Nutrition 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 16
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 16
- 239000011718 vitamin C Substances 0.000 claims abstract description 16
- 229940094952 green tea extract Drugs 0.000 claims abstract description 15
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 235000019216 blueberry extract Nutrition 0.000 claims abstract description 13
- 235000012907 honey Nutrition 0.000 claims abstract description 13
- 235000015197 apple juice Nutrition 0.000 claims abstract description 12
- 239000012141 concentrate Substances 0.000 claims abstract description 12
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 12
- 235000020733 paullinia cupana extract Nutrition 0.000 claims abstract description 12
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 12
- 229940055416 blueberry extract Drugs 0.000 claims abstract description 11
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 9
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 9
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 9
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 9
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 9
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims description 12
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 11
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 10
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 10
- 235000021014 blueberries Nutrition 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 8
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 7
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000007872 degassing Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 229910001220 stainless steel Inorganic materials 0.000 claims 1
- 239000010935 stainless steel Substances 0.000 claims 1
- 210000001508 eye Anatomy 0.000 abstract description 28
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000001179 sorption measurement Methods 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 229960005375 lutein Drugs 0.000 description 13
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 235000012680 lutein Nutrition 0.000 description 10
- 239000001656 lutein Substances 0.000 description 10
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 10
- 240000003444 Paullinia cupana Species 0.000 description 6
- 235000000556 Paullinia cupana Nutrition 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000001525 retina Anatomy 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 201000004569 Blindness Diseases 0.000 description 3
- 208000002177 Cataract Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000077233 Vaccinium uliginosum Species 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000002780 macular degeneration Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000008210 xanthophylls Nutrition 0.000 description 3
- 241000208421 Ericaceae Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- -1 carotenoid aliphatic ester Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000032677 cell aging Effects 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241001674939 Caulanthus Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 206010066786 Diabetic keratopathy Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241001610568 Vaccinioideae Species 0.000 description 1
- 235000012511 Vaccinium Nutrition 0.000 description 1
- 241000736767 Vaccinium Species 0.000 description 1
- 244000154870 Viola adunca Species 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000016127 added sugars Nutrition 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 125000002635 lutein group Chemical group 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 239000000790 retinal pigment Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及一种抗疲劳护眼营养液，包括以下重量份原料：纯净水60‑80份，牛磺酸0.3‑0.8份，瓜拉纳提取物2‑5份，绿茶提取物0.5‑1份，叶黄素酯微囊粉0.2‑0.6份，蓝莓提取物1‑3份，维生素C0.02‑0.04份，维生素B6 0.001‑0.002份，玉米黄质微囊粉0.1‑0.2份，人参提取物3‑8份，苹果浓缩汁3‑8份，低聚果糖0.5‑2份，麦芽糖5‑12份，蜂蜜0.3‑0.6份，山梨酸钾0.02‑0.06份。本发明的有益效果是，本发明的营养液解决了眼睛所需要补充的营养难题，而且大大的提高了吸收转化率的难题，同时解决了因疲劳引起的眼部不适问题。
Description
技术领域
本发明涉及眼保健品技术领域，尤其涉及一种抗疲劳护眼营养液及其制备方法。
背景技术
目前，在电子设备占据我们大多数人的视觉生活的同时，视觉疲劳及眼部各种问题也成为很多人苦恼的事情，无论是用眼过度的学生，还是每天面对电脑超过8小时的上班族，再或是上了岁数的老年人，都或多或少地出现眼睛酸涩、疲劳、疼痛、流泪等不适症状。
出现以上症状大体可分为外源性和内源性两种损伤。外源性包括各种电子设备释放蓝紫光对眼睛的直接伤害、长时间面对电子产品得不到休息而引起的视疲劳、风沙雾霾等引起的眼干涩等；内源性包括人到老年身体器官、功能开始退化，人体机能减退，如老年黄斑退化和白内障等；另外，糖尿病、高血压所导致的各种眼疾以及抽烟饮酒对眼睛的直接损伤等。
如此多的不良因素影响着我们的眼睛，看来保护眼睛，势在必行。那么，怎样才能有效预防和缓解呢？很多人做了眼保健操，也补充了维生素，可是效果并不明显。市面上也有以叶黄素为主要原料制成的产品，有片剂及胶囊等剂型，对眼部保护有一定的作用，但是其对光、热稳定性差，耐胃酸性差，容易发生降解，在人体小肠吸收过程中，生物利用率低，吸收转化率仅为60％左右。
发明内容
为解决上述技术问题，本发明提供了一种抗疲劳护眼营养液及其制备方法。
为实现上述目的，本发明采用下述技术方案：
一种抗疲劳护眼营养液，包括以下重量份原料：纯净水60-80份，牛磺酸0.3-0.8份，瓜拉纳提取物2-5份，绿茶提取物0.5-1份，叶黄素酯微囊粉0.2-0.6份，蓝莓提取物1-3份，维生素C0.02-0.04份，维生素B60.001-0.002份，玉米黄质微囊粉0.1-0.2份，人参提取物3-8份，苹果浓缩汁3-8份，低聚果糖0.5-2份，麦芽糖5-12份，蜂蜜0.3-0.6份，山梨酸钾0.02-0.06份。
一种抗疲劳护眼营养液，包括以下重量份原料：纯净水70份，牛磺酸0.5份，瓜拉纳提取物3份，绿茶提取物0.6份，叶黄素酯微囊粉0.4份，蓝莓提取物2份，维生素C0.03份，维生素B60.0012份，玉米黄质微囊粉0.2份，人参提取物5份，苹果浓缩汁6份，低聚果糖1份，麦芽糖10份，蜂蜜0.5份，山梨酸钾0.04份。
一种抗疲劳护眼营养液的制备方法，包括以下步骤：
1、原辅料称量、溶解
按照配方分别称量重量份的原料：牛磺酸、瓜拉纳提取物、绿茶提取物、叶黄素酯微囊粉、蓝莓提取物、玉米黄质微囊粉、维生素C、维生素B6、人参提取物和低聚果糖，置入不锈钢容器中并入一定量的纯净水搅拌溶解混合均匀，过滤备用；
2、调配
将步骤1中混合均匀过滤后的溶液，加入配方用量的苹果浓缩汁、山梨酸钾、麦芽糖和蜂蜜，然后加水至100％，搅拌混合均匀；
3、脱气、均质
将步骤2中混匀后的混合液，在温度40-50℃，真空度0.0078MPa-0.0105MPa下脱气，去除空气对营养液的影响，然后将调配好的营养液在60℃，压力18MPa-20MPa下，用均质机进行均质；
4、灌装、灭菌
对均质后营养液进行灌装，成品进行灭菌，灭菌温度为80℃，杀菌时间30分钟。
牛磺酸：牛磺酸在脑内的含量丰富、分布广泛，能明显促进神经系统的生长发育和细胞增殖、分化，且呈剂量依赖性，在脑神经细胞发育过程中起重要作用。猫以及夜行猫头鹰之所以要捕食老鼠，其主要原因是老鼠体内含有丰富的牛磺酸，多食可保持其锐利的视觉。牛磺酸能提高神经传导和视觉机能。
叶黄素酯微囊粉：叶黄素酯是一种重要的类胡萝卜素脂肪酸酯，它广泛存在于万寿菊花、南瓜、甘蓝、首糟等植物体内。其中，在万寿菊花中含量最为丰富，高达30％至40％。1.叶黄素酯经人体降解转化为叶黄素后，发挥其作用，最新实验研究表明，叶黄素本身的光、热稳定性，以及对人体PH值的耐受范围均不如叶黄素酯，(光、热、酸、碱、金属离子、氧化剂和还原剂对其稳定性影响较大)在储存过程及服用过程中会由于以上因素，导致叶黄素生物利用度较低，最新叶黄素相关食品制品，基本都以叶黄素酯为原料制成。2008年5月26日，国家卫生部确立批准叶黄素酯为新资源食品功效原料。2010年前后是叶黄素产品和叶黄素酯产品较大的生产分水岭。叶黄素酯在人体发挥作用过程，叶黄素酯在小肠中经胆汁和胰脂酶，水解酯化物系统共同作用，而生成游离态叶黄素，经小肠黏膜吸收。被吸收的游离态叶黄素是一种性能优异的抗氧化剂，可预防细胞衰老和机体器官衰老，同时还可预防老年性眼球视网膜黄斑退化引起的视力下降与失明，并作为癌症预防剂，生命延长剂，溃疡抵制剂，心脏病发作与冠状动脉疾病抵制剂等，在食品及医药上有深度应用。
绿茶提取物：绿茶提取物是从绿茶叶片中提取的活性成分，主要包括茶多酚(儿茶素)、咖啡碱、芳香油、水分、矿物质、色素、碳水化合物、蛋白质、氨基酸、维生素等。茶多酚具有抗氧化、清除自由基等作用。有利于保护维生素C不被氧化，有助于醒脑提神，茶叶中的咖啡碱能促使人体中枢神经兴奋，增强大脑皮层的兴奋过程，起到提神益思、清心的效果。有助于利尿解乏，茶叶中的咖啡碱可刺激肾脏，促使尿液迅速排出体外，提高肾脏的滤出率，减少有害物质在肾脏中滞留时间。咖啡碱还可排除尿液中的过量乳酸，有助于使人体尽快消除疲劳。
人参提取物：人参提取物是从五加科植物人参的根、茎叶中提取精制而成，其富含十八种人参单体皂甙，可以明显抑制脑和肝中过氧化脂质形成，减少大脑皮层和肝中脂褐素的含量，同时也能增加超氧化物歧化酶和过氧化氢酶在血液中的含量，具有抗氧化作用。还可减少体内自由基含量。延缓神经细胞衰老并降低老年发生的记忆损伤，且具有稳定膜结构和增加蛋白质合成作用，可以提高老年人记忆力能力。
玉米黄质微囊粉：玉米黄质(Zeaxanthin，3，3'-二羟基-β-胡萝卜素)，亦称玉米黄素，广泛存在于绿色叶类蔬菜、花卉、水果、枸杞和黄玉米中。主要作用1.预防老化性黄斑退化症(老年人失明的主要病因)；2.预防白内障、内膜中层增厚、心脏病；3.改善视网膜色素变性患者的病症；4.抗癌作用，阻止癌细胞的扩散。5.降低色相差，使视力更精准；保护视网膜在吸收光线时免受氧化伤害；6.玉米黄质专业供应商融升生物表示玉米黄质有降低血脂氧化、降低LDL氧化成oxLDL的作用，从而减缓动脉硬化。现已广泛应用于食品、保健品、化妆品、医药及饲料。
蓝莓提取物：蓝莓(Blueberry)，又名越桔，蓝浆果，属杜鹃花科(Ericaceae)越桔亚科(Vaccinioideae)越桔属(Vacciniodeae)植物，多年生落叶或常绿灌木或小灌木，广泛分布于北半球。蓝莓果实含有防止脑神经衰老、增强心脏功能、明目及抗癌等独特功效物质,因此被国际粮农组织列为人类五大健康食品之一。蓝莓中含的花青贰色素，具有活化视网膜功效，可以强化视力，防止眼球疲劳。保护视力，防止失明、青光明、白内障、视网膜出血、改善近视、黄斑退化、糖尿病性网膜症、色素性视网膜炎及夜盲症等。增加毛细血管的柔韧性，可以纯净促进血管膨胀和伸缩性，防止血管破裂。提供抗氧化剂，能消除使血管硬化的自由基，预防动脉硬化。既能强化眼睛里的毛细血管，当然也能强化身体其他器官组织里的毛细血管，达到预防各部器官血管病变。消灭自由基
维生素C：维生素C是组成眼球水晶体的成份之一。可减弱光线与氧气对眼睛晶状体的损害，如果缺乏维生素C就容易患水晶体浑浊的白内障病。
维生素B6：维生素B6(Vitamin B6)又称吡哆素，其包括吡哆醇、吡哆醛及吡哆胺，在体内以磷酸酯的形式存在，是一种水溶性维生素，参与一些氨基酸的代谢转化生合成。当作精神安定剂，以避免精神过敏、易受刺激等现象。缓和忧虑感。
瓜拉纳提取物：瓜拉那是亚马逊地区特产的一种野生植物，营养价值非常高，含有氨基酸、生物碱，多种矿物质、丹宁酸，多种维生素、碳水化合物，非常利于人体的组织吸收，瓜拉那提取物(Guarana extract)是瓜拉那果实经提取分离制成的产品。有提神醒脑、恢复体力、补充能量、强身健体之功效。
本发明的有益效果是，
1、该营养液的原料中包含有叶黄素酯，研究表明叶黄素酯对光、热的稳定性强，耐胃酸性及耐金属离子性强，不宜消耗降解，在生物利用率方面较叶黄素高1.6倍；叶黄素酯在人体可自然水解为游离态叶黄素，游离态叶黄素进补眼底发挥效能；
2、该复合配方中除了叶黄素酯，还配备了玉米黄质、蓝莓提取物等物质，其中玉米黄质也是视网膜中黄斑区域的重要组成部分，蓝莓中的花青素可促进视网膜细胞中视紫质的再生成，该复合配方产品运用了微囊化技术，微囊制剂肉眼看是粉状，显微镜下观看是一颗颗由特殊的囊材包裹的微小胶囊，该微囊制剂的最大优点是靶向定位分解，有效率可提高90％-200％，而且本身不溶于水的叶黄素脂经过微囊化后可溶于水。
3、人的中枢神经系统及视网膜都含有较多的牛磺酸，它对维持正常的视觉功能起到重要作用，配方中含的牛磺酸和人参提取物，人参提取物含有的人参皂甙适用于疲劳过度及神经衰弱等症状，具有增强人体表面细胞活力的作用。
4、本发明不仅解决了眼睛所需要补充的营养难题，而且大大的提高了吸收转化率的难题，同时解决了因疲劳引起的眼部不适问题。
具体实施方式
实施例1
一种抗疲劳护眼营养液，包括以下重量份原料：纯净水70份，牛磺酸0.5份，瓜拉纳提取物3份，绿茶提取物0.6份，叶黄素酯微囊粉0.4份，蓝莓提取物2份，维生素C0.03份，维生素B60.0012份，玉米黄质微囊粉0.2份，人参提取物5份，苹果浓缩汁6份，低聚果糖1份，麦芽糖10份，蜂蜜0.5份，山梨酸钾0.04份。
上述抗疲劳护眼营养液的制备方法，包括以下步骤：
1、分别称量0.5份牛磺酸，3份瓜拉纳提取物，绿茶提取物0.6份，0.4份叶黄素酯微囊粉，2份蓝莓提取物，0.03份维生素C，维生素B60.0012份，0.2份玉米黄质微囊粉，5份人参提取物和1份低聚果糖，置入不锈钢容器中并入70份纯净水搅拌混合均匀，过滤备用；
2、将步骤1中均匀并过滤后的溶液，再与称量后的6份苹果浓缩汁，0.04份山梨酸钾，10份麦芽糖和0.5份蜂蜜，然后加水至100％，搅拌混合均匀；
3、将步骤2中混匀后的混合液，在温度40℃，真空度0.01MPa下脱气，去除空气对营养液的影响，然后将调配好的营养液在60℃，压力19MPa下，用均质机进行均质；
4、对均质后营养液进行灌装，成品进行灭菌，灭菌温度为80℃，杀菌时间30分钟。
实施例2
一种抗疲劳护眼营养液，包括以下重量份原料：纯净水75份，牛磺酸0.7份，瓜拉纳提取物5份，绿茶提取物0.8份，叶黄素酯微囊粉0.3份，蓝莓提取物3份，维生素C0.04份，维生素B60.0018份，玉米黄质微囊粉0.1份，人参提取物7份，苹果浓缩汁4份，低聚果糖2份，麦芽糖6份，蜂蜜0.3份，山梨酸钾0.03份。
上述抗疲劳护眼营养液的制备方法，包括以下步骤：
1、分别称量0.7份牛磺酸，5份瓜拉纳提取物，绿茶提取物0.8份，0.3份叶黄素酯微囊粉，3份蓝莓提取物，0.04份维生素C，维生素B60.0018份，0.1份玉米黄质微囊粉，7份人参提取物和2份低聚果糖，置入不锈钢容器中并入75份纯净水搅拌混合均匀，过滤备用；
2、将步骤1中均匀并过滤后的溶液，再与称量后的4份苹果浓缩汁，0.03份山梨酸钾，6麦芽糖和0.3份蜂蜜，然后加水至100％，搅拌混合均匀；
3、将步骤2中混匀后的混合液，在温度45℃，真空度0.009MPa下脱气，去除空气对营养液的影响，然后将调配好的营养液在60℃，压力20MPa下，用均质机进行均质；
4、对均质后营养液进行灌装，成品进行灭菌，灭菌温度为80℃，杀菌时间30分钟。
实施例3
一种抗疲劳护眼营养液，包括以下重量份原料：纯净水60份，牛磺酸0.3份，瓜拉纳提取物2份，绿茶提取物0.5份，叶黄素酯微囊粉0.2份，蓝莓提取物1份，维生素C0.02份，维生素B60.001份，玉米黄质微囊粉0.2份，人参提取物4份，苹果浓缩汁3份，低聚果糖0.5份，麦芽糖5份，蜂蜜0.5份，山梨酸钾0.04份。
上述抗疲劳护眼营养液的制备方法，包括以下步骤：
1、分别称量0.3份牛磺酸，2份瓜拉纳提取物，绿茶提取物0.5份，0.2份叶黄素酯微囊粉，1份蓝莓提取物，0.02份维生素C，维生素B60.001份，0.2份玉米黄质微囊粉，4份人参提取物和0.5份低聚果糖，置入不锈钢容器中并入60份纯净水搅拌混合均匀，过滤备用；
2、将步骤1中均匀并过滤后的溶液，再与称量后的3份苹果浓缩汁，0.04份山梨酸钾，5份麦芽糖和0.5份蜂蜜，然后加水至100％，搅拌混合均匀；
3、将步骤2中混匀后的混合液，在温度50℃，真空度0.008MPa下脱气，去除空气对营养液的影响，然后将调配好的营养液在60℃，压力18MPa下，用均质机进行均质；
4、对均质后营养液进行灌装，成品进行灭菌，灭菌温度为80℃，杀菌时间30分钟。
本发明未经描述的技术特征可以通过现有技术实现，在此不再赘述。当然，上述说明并非是对本发明的限制，本发明也不仅限于上述举例，本技术领域普通技术人员在本发明的实质范围内所作出的变化、改型、添加或更换，也应属于本发明的保护范围。
Claims (3)
1.一种抗疲劳护眼营养液，其特征在于，包括以下重量份原料：纯净水60-80份，牛磺酸0.3-0.8份，瓜拉纳提取物2-5份，绿茶提取物0.5-1份，叶黄素酯微囊粉0.2-0.6份，蓝莓提取物1-3份，维生素C0.02-0.04份，维生素B60.001-0.002份，玉米黄质微囊粉0.1-0.2份，人参提取物3-8份，苹果浓缩汁3-8份，低聚果糖0.5-2份，麦芽糖5-12份，蜂蜜0.3-0.6份，山梨酸钾0.02-0.06份。
2.如权利要求1所述的一种抗疲劳护眼营养液，其特征在于，包括以下重量份原料：纯净水70份，牛磺酸0.5份，瓜拉纳提取物3份，绿茶提取物0.6份，叶黄素酯微囊粉0.4份，蓝莓提取物2份，维生素C0.03份，维生素B60.0012份，玉米黄质微囊粉0.2份，人参提取物5份，苹果浓缩汁6份，低聚果糖1份，麦芽糖10份，蜂蜜0.5份，山梨酸钾0.04份。
3.如权利要求1或2所述的抗疲劳护眼营养液的制备方法，其特征在于，包括以下步骤：
1、原辅料称量、溶解
按照配方分别称量重量份的原料:牛磺酸、瓜拉纳提取物、绿茶提取物、叶黄素酯微囊粉、蓝莓提取物、玉米黄质微囊粉、维生素C、维生素B6、人参提取物和低聚果糖，置入不锈钢容器中并入一定量的纯净水搅拌溶解混合均匀，过滤备用；
2、调配
将步骤1中混合均匀并过滤后的溶液，加入配方用量的苹果浓缩汁、山梨酸钾、麦芽糖和蜂蜜，然后加水至100％，搅拌混合均匀；
3、脱气、均质
将步骤2中混匀后的混合液，在温度40-50℃，真空度0.0078MPa-0.0105MPa下脱气，去除空气对营养液的影响，然后将调配好的营养液在60℃，压力18MPa-20MPa下，用均质机进行均质；
4、灌装、灭菌
对均质后营养液进行灌装，成品进行灭菌，灭菌温度为80℃，杀菌时间30分钟。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810456608.3A CN108713760A (zh) | 2018-05-14 | 2018-05-14 | 一种抗疲劳护眼营养液及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810456608.3A CN108713760A (zh) | 2018-05-14 | 2018-05-14 | 一种抗疲劳护眼营养液及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108713760A true CN108713760A (zh) | 2018-10-30 |
Family
ID=63899830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810456608.3A Pending CN108713760A (zh) | 2018-05-14 | 2018-05-14 | 一种抗疲劳护眼营养液及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108713760A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109985082A (zh) * | 2019-04-11 | 2019-07-09 | 中国科学院城市环境研究所 | 一种用于抗氧化及缓解视疲劳的药物、保健品或食品 |
| CN110051004A (zh) * | 2019-04-10 | 2019-07-26 | 张秀惠 | 一种具有护眼功能的组合物及其制备方法 |
| CN110477123A (zh) * | 2019-07-25 | 2019-11-22 | 珠海市微豆生物技术有限公司 | 一种具有改善眼睛疲劳作用的植物蛋白固体饮料及其制备方法 |
| CN112870248A (zh) * | 2021-02-20 | 2021-06-01 | 东莞市金基环保科技有限公司 | 一种用于纳米喷雾器中的植物负离子护眼液及其制备方法 |
| CN113367256A (zh) * | 2021-05-12 | 2021-09-10 | 中瑞德泰生物科技集团有限公司 | 一种护眼饮料及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101248873A (zh) * | 2008-04-03 | 2008-08-27 | 四川健丰科技发展有限公司 | 具有视力保护功能的饮用食品 |
| CN102150724A (zh) * | 2011-03-30 | 2011-08-17 | 姜天安 | 一种提神缓解体力和视觉疲劳的功能性混合物及其应用 |
| CN106138199A (zh) * | 2016-07-29 | 2016-11-23 | 青岛尚医制药有限公司 | 一种提供眼睛营养保护视力的复合配方及其制备方法 |
| CN107375504A (zh) * | 2017-08-15 | 2017-11-24 | 庞会心 | 一种预防和治疗视疲劳的组合物及其制备方法与应用 |
| CN107518121A (zh) * | 2017-08-30 | 2017-12-29 | 江苏德和生物科技有限公司 | 一种缓解体力疲劳的天然组合物及其制备方法 |
-
2018
- 2018-05-14 CN CN201810456608.3A patent/CN108713760A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101248873A (zh) * | 2008-04-03 | 2008-08-27 | 四川健丰科技发展有限公司 | 具有视力保护功能的饮用食品 |
| CN102150724A (zh) * | 2011-03-30 | 2011-08-17 | 姜天安 | 一种提神缓解体力和视觉疲劳的功能性混合物及其应用 |
| CN106138199A (zh) * | 2016-07-29 | 2016-11-23 | 青岛尚医制药有限公司 | 一种提供眼睛营养保护视力的复合配方及其制备方法 |
| CN107375504A (zh) * | 2017-08-15 | 2017-11-24 | 庞会心 | 一种预防和治疗视疲劳的组合物及其制备方法与应用 |
| CN107518121A (zh) * | 2017-08-30 | 2017-12-29 | 江苏德和生物科技有限公司 | 一种缓解体力疲劳的天然组合物及其制备方法 |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110051004A (zh) * | 2019-04-10 | 2019-07-26 | 张秀惠 | 一种具有护眼功能的组合物及其制备方法 |
| CN109985082A (zh) * | 2019-04-11 | 2019-07-09 | 中国科学院城市环境研究所 | 一种用于抗氧化及缓解视疲劳的药物、保健品或食品 |
| CN109985082B (zh) * | 2019-04-11 | 2021-11-09 | 中国科学院城市环境研究所 | 一种用于抗氧化及缓解视疲劳的药物、保健品或食品 |
| CN110477123A (zh) * | 2019-07-25 | 2019-11-22 | 珠海市微豆生物技术有限公司 | 一种具有改善眼睛疲劳作用的植物蛋白固体饮料及其制备方法 |
| CN112870248A (zh) * | 2021-02-20 | 2021-06-01 | 东莞市金基环保科技有限公司 | 一种用于纳米喷雾器中的植物负离子护眼液及其制备方法 |
| CN113367256A (zh) * | 2021-05-12 | 2021-09-10 | 中瑞德泰生物科技集团有限公司 | 一种护眼饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108713760A (zh) | 一种抗疲劳护眼营养液及其制备方法 | |
| CN103735733B (zh) | 一种含叶黄素酯的复方制剂及其制备方法 | |
| CN102742656B (zh) | 一种缓解视力疲劳的奶茶及其制备方法 | |
| CN108524667A (zh) | 一种具有缓解视疲劳作用的叶黄素酯组合物及其制备方法 | |
| CN107837288A (zh) | 一种缓解视疲劳的复方花青素叶黄素酯软胶囊 | |
| JP2008271878A (ja) | 新規飲食品 | |
| CN106889617A (zh) | 一种眼保健食品、其制备方法和应用 | |
| CN107410643A (zh) | 具有缓解视疲劳的雨生红球藻压片糖果及其制备方法 | |
| CN104257727A (zh) | 缓解视疲劳软胶囊及加工方法 | |
| CN102907735A (zh) | 明目功能饮料加工工艺及产品制备 | |
| CN101283806A (zh) | 一种含天然叶黄素的膳食补充剂及制备工艺 | |
| CN111202243A (zh) | 强化明目营养软胶囊特殊膳食食品及其制备方法 | |
| CN104055180A (zh) | 高硒锗酵素酶饮料 | |
| CN101416741A (zh) | 一种用于缓解视疲劳的保健食品 | |
| CN107252095A (zh) | 复合酵素及其制备方法 | |
| CN101069709A (zh) | 一种营养保健胶囊 | |
| CN109619189A (zh) | 一种沙棘黑果花楸护眼奶片及其制备方法 | |
| CN109043249A (zh) | 一种蓝莓l-阿拉伯糖复合饮料浓浆 | |
| CN109645295A (zh) | 一种维持心血管系统健康的雨生红球藻虾青素固体饮料 | |
| CN104957618A (zh) | 一种铁皮石斛鱼油护眼胶囊 | |
| CN101955874A (zh) | 一种苦杏酒的酿造方法 | |
| CN104939093A (zh) | 低糖瓜蒌籽油乳剂 | |
| KR20010016591A (ko) | 홍경천 추출물 제조방법과 그 용도 | |
| CN104432392A (zh) | 一种强心抗衰老蓝莓固体颗粒饮料及其制备方法 | |
| CN107439866A (zh) | 枸杞鹰嘴豆植物营养素饮料及其制备工艺 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: No.373 Huantai North Road, Wangtai Town, Huangdao District, Qingdao City, Shandong Province Applicant after: Qingdao Shihai Shengke Pharmaceutical Co.,Ltd. Address before: No.373 Huantai North Road, Wangtai Town, Huangdao District, Qingdao City, Shandong Province Applicant before: QINGDAO OUPUKAI PHARMACEUTICAL Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181030 |
|
| WD01 | Invention patent application deemed withdrawn after publication |